FI93444B - Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi

Info

Publication number
FI93444B
FI93444B FI884471A FI884471A FI93444B FI 93444 B FI93444 B FI 93444B FI 884471 A FI884471 A FI 884471A FI 884471 A FI884471 A FI 884471A FI 93444 B FI93444 B FI 93444B
Authority
FI
Finland
Prior art keywords
preparation
therapeutically active
dihydropyridine derivatives
active dihydropyridine
derivatives
Prior art date
Application number
FI884471A
Other languages
English (en)
Swedish (sv)
Other versions
FI884471A (fi
FI884471A0 (fi
FI93444C (fi
Inventor
Kelvin Cooper
Michael Jonathan Fray
Kenneth Richardson
John Steele
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878722977A external-priority patent/GB8722977D0/en
Priority claimed from GB888804441A external-priority patent/GB8804441D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of FI884471A0 publication Critical patent/FI884471A0/fi
Publication of FI884471A publication Critical patent/FI884471A/fi
Publication of FI93444B publication Critical patent/FI93444B/fi
Application granted granted Critical
Publication of FI93444C publication Critical patent/FI93444C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI884471A 1987-09-30 1988-09-29 Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi FI93444C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8722977 1987-09-30
GB878722977A GB8722977D0 (en) 1987-09-30 1987-09-30 Therapeutic agents
GB8804441 1988-02-25
GB888804441A GB8804441D0 (en) 1988-02-25 1988-02-25 Therapeutic agents

Publications (4)

Publication Number Publication Date
FI884471A0 FI884471A0 (fi) 1988-09-29
FI884471A FI884471A (fi) 1989-03-31
FI93444B true FI93444B (fi) 1994-12-30
FI93444C FI93444C (fi) 1995-04-10

Family

ID=26292797

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884471A FI93444C (fi) 1987-09-30 1988-09-29 Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi

Country Status (26)

Country Link
US (3) US4935430A (fi)
EP (1) EP0310386B1 (fi)
JP (2) JP2660016B2 (fi)
KR (1) KR900008318B1 (fi)
CN (1) CN1032648C (fi)
AU (2) AU597190B2 (fi)
CA (1) CA1340785C (fi)
CY (1) CY1722A (fi)
DE (1) DE3866077D1 (fi)
DK (1) DK170376B1 (fi)
EG (1) EG18563A (fi)
ES (1) ES2038766T3 (fi)
FI (1) FI93444C (fi)
GR (1) GR3003468T3 (fi)
HK (1) HK66093A (fi)
HU (1) HU201061B (fi)
IE (1) IE61045B1 (fi)
IL (1) IL101332A0 (fi)
MY (1) MY104933A (fi)
NO (1) NO168107C (fi)
NZ (1) NZ226397A (fi)
PH (1) PH26046A (fi)
PL (1) PL157186B1 (fi)
PT (1) PT88614B (fi)
SG (1) SG49393G (fi)
YU (1) YU46698B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906324D0 (en) * 1989-03-20 1989-05-04 Pfizer Ltd 1,4-dihydropyridines
US4990518A (en) * 1989-09-13 1991-02-05 G. D. Searle & Co. Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines
GB9010404D0 (en) * 1990-05-09 1990-06-27 Pfizer Ltd Therapeutic agents
GB9015524D0 (en) * 1990-07-13 1990-08-29 Pfizer Ltd Therapeutic agents
GB9019409D0 (en) * 1990-09-05 1990-10-17 Pfizer Ltd Therapeutic agents
KR100195433B1 (ko) * 1990-11-30 1999-06-15 오쓰까 아끼히꼬 활성산소 억제제
US5288866A (en) * 1991-12-20 1994-02-22 American Cyanamid Company 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
BR9910864A (pt) * 1998-06-04 2002-02-05 Abbott Lab Compostos anti-inflamatórios para inibição de aderência celular
EP1181296A1 (en) * 1999-06-03 2002-02-27 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
AU7931301A (en) * 2000-08-04 2002-02-18 Dmi Biosciences Inc Method of using diketopiperazines and composition containing them
KR20120091266A (ko) 2003-05-15 2012-08-17 디엠아이 바이오사이언시스, 인크 T-세포 매개성 질환의 치료 방법
CN113999167B (zh) * 2021-10-18 2023-09-29 蚌埠中实化学技术有限公司 一种4-氯-2,6-二甲基-3-硝基吡啶的制备方法
CN117568743B (zh) * 2024-01-15 2024-03-19 江苏普坦科金属科技有限公司 一种铁基材料的表面耐腐蚀耐磨处理工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
US4317909A (en) * 1980-03-24 1982-03-02 Sterling Drug Inc. Preparation of 1,3-dihydro-5-(pyridinyl)-2H-imidazo[4,5-b]pyridin-2-ones
US4353905A (en) 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
ATE20064T1 (de) 1982-07-22 1986-06-15 Pfizer Anti-ischaemische und antihypertensive dihydropyridin-derivate.
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8620880D0 (en) * 1986-08-29 1986-10-08 Pfizer Ltd Therapeutic agents
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
NO874194L (no) 1986-11-07 1988-05-09 Pfizer Ltd Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
US4820842A (en) * 1986-11-19 1989-04-11 Warner-Lambert Company 2-substituted-1,4-dihydropyridines
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
GB8803963D0 (en) * 1988-02-19 1988-03-23 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
AU597190B2 (en) 1990-05-24
CY1722A (en) 1994-05-06
SG49393G (en) 1993-07-09
US4935430A (en) 1990-06-19
NO168107C (no) 1992-01-15
HUT48872A (en) 1989-07-28
FI884471A (fi) 1989-03-31
US5063237A (en) 1991-11-05
AU617256B2 (en) 1991-11-21
US5120747A (en) 1992-06-09
IE882944L (en) 1989-03-30
NO884333L (no) 1989-03-31
KR900008318B1 (ko) 1990-11-12
PL274977A1 (en) 1989-08-21
CN1032648C (zh) 1996-08-28
KR890005054A (ko) 1989-05-11
PT88614B (pt) 1993-07-30
HU201061B (en) 1990-09-28
PH26046A (en) 1992-01-29
DK544588A (da) 1989-05-11
YU46698B (sh) 1994-04-05
FI884471A0 (fi) 1988-09-29
YU182088A (en) 1990-06-30
JP2898256B2 (ja) 1999-05-31
PL157186B1 (pl) 1992-05-29
IL101332A0 (en) 1992-11-15
AU2297388A (en) 1989-04-06
FI93444C (fi) 1995-04-10
JP2660016B2 (ja) 1997-10-08
HK66093A (en) 1993-07-16
GR3003468T3 (en) 1993-02-17
NZ226397A (en) 1990-11-27
PT88614A (pt) 1989-07-31
EG18563A (en) 1993-08-30
DK170376B1 (da) 1995-08-14
CN1032439A (zh) 1989-04-19
DK544588D0 (da) 1988-09-29
CA1340785C (en) 1999-10-12
JPH09315973A (ja) 1997-12-09
IE61045B1 (en) 1994-09-07
DE3866077D1 (de) 1991-12-12
JPH01113367A (ja) 1989-05-02
NO884333D0 (no) 1988-09-29
NO168107B (no) 1991-10-07
MY104933A (en) 1994-07-30
ES2038766T3 (es) 1993-08-01
EP0310386A2 (en) 1989-04-05
EP0310386B1 (en) 1991-11-06
AU6126190A (en) 1990-11-29
EP0310386A3 (en) 1989-11-15

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI91152B (fi) Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI881223A0 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI96601C (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI883997A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
NO177263C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater
NO173330C (no) Anologifremgangsm}te for fremstilling av terapeutisk aktive pyrrolidin-derivater
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI893121A (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: PFIZER LIMITED

MA Patent expired